Literature DB >> 23456204

Disseminated Mycobacterium avium complex infection in a patient carrying autoantibody to interferon-γ.

Takashi Ishii1, Atsuhisa Tamura, Hirotoshi Matsui, Hideaki Nagai, Shinobu Akagawa, Akira Hebisawa, Ken Ohta.   

Abstract

A 66-year-old man was admitted to our hospital on suspicion of lung cancer with bone metastasis. He suffered multiple joint and muscle pain. 18F-Fluorodeoxy glucose positron emission tomography (FDG-PET) showed multiple accumulations in the lung, bones including the vertebrae, and mediastinal lymph nodes. Anti-human immunodeficiency virus (HIV) antibody was negative. Because Mycobacterium avium complex (MAC) was isolated from bronchial lavage fluid, bronchial wall, peripheral blood, and muscle abscess, he was diagnosed as having disseminated MAC infection. Although multidrug chemotherapy was initiated, his condition rapidly deteriorated at first. After surgical curettage of the musculoskeletal abscess, his condition gradually improved. As for etiology, we suspected that neutralizing factors against interferon-gamma (IFN-γ) might be present in his serum because a whole blood IFN-γ release assay detected low IFN-γ level even with mitogen stimulation. By further investigation, autoantibodies to IFN-γ were detected, suggesting the cause of severe MAC infection. We should consider the presence of autoantibodies to IFN-γ when a patient with disseminated NTM infection does not indicate the presence of HIV infection or other immunosuppressive condition.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23456204     DOI: 10.1007/s10156-013-0572-2

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  12 in total

1.  Late-Onset Disseminated Mycobacterium avium intracellulare Complex Infection (MAC), Cerebral Toxoplasmosis and Salmonella Sepsis in a German Caucasian Patient with Unusual Anti-Interferon-Gamma IgG1 Autoantibodies.

Authors:  Leif G Hanitsch; Madlen Löbel; Holger Müller-Redetzky; Mariana Schürmann; Norbert Suttorp; Nadine Unterwalder; Ulrike Mönnich; Christian Meisel; Kirsten Wittke; Hans-Dieter Volk; Carmen Scheibenbogen; Uwe Kölsch
Journal:  J Clin Immunol       Date:  2015-04-15       Impact factor: 8.317

2.  Recurrent Burkholderia gladioli suppurative lymphadenitis associated with neutralizing anti-IL-12p70 autoantibodies.

Authors:  Bich-Thuy T Sim; Sarah K Browne; Marguerite Vigliani; Dalila Zachary; Lindsey Rosen; Steven M Holland; Steven M Opal
Journal:  J Clin Immunol       Date:  2013-05-26       Impact factor: 8.317

3.  Recurrence of disseminated Mycobacterium avium complex disease in a patient with anti-gamma interferon autoantibodies by reinfection.

Authors:  Tomoyasu Nishimura; Yukiko Fujita-Suzuki; Makoto Yonemaru; Kiyofumi Ohkusu; Takuro Sakagami; Stephen M Carpenter; Yoshihito Otsuka; Ho Namkoong; Ikuya Yano; Naoki Hasegawa
Journal:  J Clin Microbiol       Date:  2015-02-04       Impact factor: 5.948

Review 4.  Inherited and acquired immunodeficiencies underlying tuberculosis in childhood.

Authors:  Stéphanie Boisson-Dupuis; Jacinta Bustamante; Jamila El-Baghdadi; Yildiz Camcioglu; Nima Parvaneh; Safaa El Azbaoui; Aomar Agader; Amal Hassani; Naima El Hafidi; Nidal Alaoui Mrani; Zineb Jouhadi; Fatima Ailal; Jilali Najib; Ismail Reisli; Adil Zamani; Sebnem Yosunkaya; Saniye Gulle-Girit; Alisan Yildiran; Funda Erol Cipe; Selda Hancerli Torun; Ayse Metin; Basak Yildiz Atikan; Nevin Hatipoglu; Cigdem Aydogmus; Sara Sebnem Kilic; Figen Dogu; Neslihan Karaca; Guzide Aksu; Necil Kutukculer; Melike Keser-Emiroglu; Ayper Somer; Gonul Tanir; Caner Aytekin; Parisa Adimi; Seyed Alireza Mahdaviani; Setareh Mamishi; Aziz Bousfiha; Ozden Sanal; Davood Mansouri; Jean-Laurent Casanova; Laurent Abel
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

5.  Differential Impairment of Interferon-γ Responses in Two Cases of Pulmonary Nontuberculous Mycobacterial Disease.

Authors:  William Rae; Yifang Gao; Efrem Eren; Rainer Döffinger; Ben Marshall; Anthony P Williams
Journal:  Case Reports Immunol       Date:  2016-11-16

6.  Severe Disseminated Mycobacterium avium Infection in a Patient with a Positive Serum Autoantibody to Interferon-γ.

Authors:  Hiroshi Ikeda; Kiwamu Nakamura; Mei Ikenori; Takahiro Saito; Keisuke Nagamine; Minoru Inoue; Takuro Sakagami; Hiroko Suzuki; Mariko Usui; Keiji Kanemitsu; Akinori Matsumoto; Takuro Shinbo
Journal:  Intern Med       Date:  2016-10-15       Impact factor: 1.271

7.  Disseminated Mycobacterium intracellulare infection with multiple abscesses on extremities in a woman with chronic corticosteroid therapy.

Authors:  Kenichiro Yaita; Hisashi Akiyoshi; Ichiro Nakae; Yuji Kawasaki; Kenjiro Nakama; Yoshiro Sakai; Kenji Masunaga; Hiroshi Watanabe
Journal:  J Gen Fam Med       Date:  2017-06-15

8.  Disseminated Mycobacterium avium Infection Presenting with Bladder Lesions in a Patient with Interferon-γ-neutralizing Autoantibodies.

Authors:  Koichi Miyashita; Shun Matsuura; Kenichi Tajima; Shogo Tajima; Ami Aoki; Takuro Sakagami; Naoki Koshimizu; Mikio Toyoshima; Takafumi Suda
Journal:  Intern Med       Date:  2018-05-18       Impact factor: 1.271

9.  Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon-γ autoantibodies and disseminated nontuberculous mycobacterial infections.

Authors:  Chih-Yu Chi; Chia-Hao Lin; Mao-Wang Ho; Jing-Ya Ding; Wen-Chi Huang; Han-Po Shih; Chun-Fu Yeh; Chang-Phone Fung; Hsin-Yun Sun; Ching-Tai Huang; Ting-Shu Wu; Chih-Yen Chang; Yuag-Meng Liu; Jia-Yih Feng; Wei-Kai Wu; Lih-Shinn Wang; Chung-Hao Tsai; Cheng-Mao Ho; Huang-Shen Lin; Hung-Jen Chen; Po-Chang Lin; Wei-Chin Liao; Wei-Ting Chen; Chia-Chi Lo; Shang-Yu Wang; Chen-Yen Kuo; Chen-Hsiang Lee; Cheng-Lung Ku
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

10.  Intravenous Cyclophosphamide Therapy for Anti-IFN-Gamma Autoantibody-Associated Mycobacterium abscessus Infection.

Authors:  Ploenchan Chetchotisakd; Siriluck Anunnatsiri; Ratanavadee Nanagara; Arnone Nithichanon; Ganjana Lertmemongkolchai
Journal:  J Immunol Res       Date:  2018-12-30       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.